Ayman El Deeb – Cluster Head, Astellas Egypt
Ayman El Deeb, cluster head of Astellas Egypt, highlights how the Egyptian affiliate of Astellas has been performing since its establishment five years ago. He also discusses the need for…
MINAPHARM ranks among the leading pharmaceutical companies in Egypt and the Middle East. The company maintains one of the broadest quality-products portfolio within the industry. Their longstanding expertise covers a broad spectrum of medicines, ranging from small molecules to extremely complex bioengineered proteins. Minapharm is leading a transition towards high-value biologicals in developing markets, while expanding a robust small-molecule setup in a business model that represents a far departure from existing regional models. In addition to production of life-saving and life-enhancing medicines, MINAPHARM is adopting an international operation platform for biotechnology and cellular engineering. Novel scientific solutions and technologies contribute to the development of products that were unimaginable a decade ago. Scientific excellence and expertise in cellular and bioprocess engineering enable the companies mission to provide not only developed markets, but also emerging markets with significant economic molecules, thus striking the next frontier. MINAPHARM is constantly demonstrating its ability to achieve the balance between Innovation and Affordability, hence, facing the most complex challenges of unmet medical needs in emerging countries.
Contact
El-Bardissi St., 2T Takseem Asmaa Fahmy St., Heliopolis, Cairo – Egypt.
(+202) 2414-3170/1/2/3/4/5
(+202) 2414-3179
Ayman El Deeb, cluster head of Astellas Egypt, highlights how the Egyptian affiliate of Astellas has been performing since its establishment five years ago. He also discusses the need for…
On Tuesday, February 12th, Pharmaboardroom attended a breakfast event hosted by the British Egyptian Business Association (BEBA) on competition law at the Cairo Semiramis Intercontinental Hotel. The theme for the…
Tarek Tawfik, managing director of AmCham Egypt, explains how Egypt’s latest economic reforms have transformed the country into an attractive destination for foreign investors. He highlights the special role of…
Nadia Lamloum, executive director of the British Egyptian Business Association (BEBA), discusses the role of her institution and the investment opportunities that Egypt has to offer, as well as the…
Dr Magdy Abdelhamid, president of the Egyptian Society of Cardiology, explains the main trends in cardiology in Egypt and the society’s prevention projects. He also gives insights into the latest…
Hassan Behnam, managing director of the French Chamber of Commerce and Industry in Egypt explains the investment opportunities Egypt has to offer, examines the close relationship between Egypt and France…
Last week saw the first meeting of the board of Egypt’s new Universal Healthcare Authority (UHA) managed by the Minister of Finance, Mohamed Maait. Created to oversee the implementation of…
Egypt continues to struggle with fake drugs reaching the hands of patients as the suppliers of counterfeit medicines become more sophisticated by adding company logos to packaging. The Egyptian police…
The Health Committee of the Egyptian House of Representatives is preparing to discuss a draft law from the government on the establishment of the “Egyptian Drug Authority.” The new…
Egypt has found a way to profit from the country’s access to cheap Hep C drugs by offering package holidays to tourists suffering from the disease, but the ‘tour and…
With the highest rate of Hepatitis C on the planet, Egypt is now making great efforts to eradicate the disease in the north MENA regions. Hep C is a disease…
As Egypt continues to grapple with the proliferation of the hepatitis C virus, fresh treatment, prevention and market access pathways are now being applied. Given the severity of Egypt’s hepatitis…
See our Cookie Privacy Policy Here